These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

695 related items for PubMed ID: 25110418

  • 1. Colorectal cancer in inflammatory bowel disease: the risk, pathogenesis, prevention and diagnosis.
    Kim ER, Chang DK.
    World J Gastroenterol; 2014 Aug 07; 20(29):9872-81. PubMed ID: 25110418
    [Abstract] [Full Text] [Related]

  • 2. Colorectal cancer in inflammatory bowel disease: what is the real magnitude of the risk?
    Dyson JK, Rutter MD.
    World J Gastroenterol; 2012 Aug 07; 18(29):3839-48. PubMed ID: 22876036
    [Abstract] [Full Text] [Related]

  • 3. Colorectal Cancer in Patients With Inflammatory Bowel Disease: The Need for a Real Surveillance Program.
    Fornaro R, Caratto M, Caratto E, Caristo G, Fornaro F, Giovinazzo D, Sticchi C, Casaccia M, Andorno E.
    Clin Colorectal Cancer; 2016 Sep 07; 15(3):204-12. PubMed ID: 27083409
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Inflammatory bowel disease as a risk factor for colorectal cancer.
    Lukas M.
    Dig Dis; 2010 Sep 07; 28(4-5):619-624. PubMed ID: 21088413
    [Abstract] [Full Text] [Related]

  • 7. Mesalamine protects against colorectal cancer in inflammatory bowel disease.
    Tang J, Sharif O, Pai C, Silverman AL.
    Dig Dis Sci; 2010 Jun 07; 55(6):1696-703. PubMed ID: 19705280
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Colorectal cancer surveillance in inflammatory bowel disease: the search continues.
    Ahmadi A, Polyak S, Draganov PV.
    World J Gastroenterol; 2009 Jan 07; 15(1):61-6. PubMed ID: 19115469
    [Abstract] [Full Text] [Related]

  • 10. Chemoprevention of colorectal cancer in inflammatory bowel disease.
    Subramanian V, Logan RF.
    Best Pract Res Clin Gastroenterol; 2011 Aug 07; 25(4-5):593-606. PubMed ID: 22122774
    [Abstract] [Full Text] [Related]

  • 11. Surveillance strategies in inflammatory bowel disease.
    Schmidt C, Bielecki C, Felber J, Stallmach A.
    Minerva Gastroenterol Dietol; 2010 Jun 07; 56(2):189-201. PubMed ID: 20485256
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Colitis-associated colorectal carcinoma: epidemiology, pathogenesis and early diagnosis].
    Scharl M, Biedermann L, Rogler G.
    Praxis (Bern 1994); 2014 Jan 29; 103(3):149-54. PubMed ID: 24468454
    [Abstract] [Full Text] [Related]

  • 15. Patients' knowledge and fear of colorectal cancer risk in inflammatory bowel disease.
    Lopez A, Collet-Fenetrier B, Belle A, Peyrin-Biroulet L.
    J Dig Dis; 2016 Jun 29; 17(6):383-91. PubMed ID: 27129893
    [Abstract] [Full Text] [Related]

  • 16. Cancer in inflammatory bowel disease.
    Xie J, Itzkowitz SH.
    World J Gastroenterol; 2008 Jan 21; 14(3):378-89. PubMed ID: 18200660
    [Abstract] [Full Text] [Related]

  • 17. Inflammatory bowel disease associated neoplasia: A surgeon's perspective.
    Althumairi AA, Lazarev MG, Gearhart SL.
    World J Gastroenterol; 2016 Jan 21; 22(3):961-73. PubMed ID: 26811640
    [Abstract] [Full Text] [Related]

  • 18. Colorectal Cancer Screening in Inflammatory Bowel Disease.
    Sengupta N, Yee E, Feuerstein JD.
    Dig Dis Sci; 2016 Apr 21; 61(4):980-9. PubMed ID: 26646250
    [Abstract] [Full Text] [Related]

  • 19. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Apr 21; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 20. Overview of molecular pathways in inflammatory bowel disease associated with colorectal cancer development.
    Azer SA.
    Eur J Gastroenterol Hepatol; 2013 Mar 21; 25(3):271-81. PubMed ID: 23169309
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 35.